Metraipolis › archive › dc_2d7fcaae578a
Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41081790
- DOI
- 10.1007/s00210-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:02:03.855Z
- SHA-256 of the archived text
28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507- Stable URL of this page
https://metraipolis.com/documento/dc_2d7fcaae578a
How to cite
Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790 — Europe PMC (en), https://europepmc.org/article/MED/41081790 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d7fcaae578a (Metraipolis archive dc_2d7fcaae578a, sha256 28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507)
BibTeX
@misc{dc2d7fcaae578a,
title = {Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41081790},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d7fcaae578a; sha256 28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081790. Agents can read the archived copy with the MCP tool read_document.